Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448-1456.
Kotzan J, Wade W, Yu HH. Assessing NSAID prescription use as a predispo-sing factor for gastroesophageal reflux diseae in a Medicaid population. Pharm Res. 2001;18:1367-1372.
Flook N, Jones R, Vaikil N. Approach to gastroesophageal reflux disease in primary care: putting the Montreal definition into practice. Can Fam Physician. 2008;54:701-705.
Liker H, Hungin P, Ingela W. Managing gastroesophageal reflux disease in primary care: the patient perspective. J Am Board Fam Pract. 2005;18:393-400.
Hawkey CJ, Langman MJS. Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut. 2003;52:600-608.
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1277 | 873 | 13 |
Full Text Views | 26 | 3 | 0 |
PDF Downloads | 0 | 0 | 0 |